Page last updated: 2024-10-28

haloperidol and Growth Disorders

haloperidol has been researched along with Growth Disorders in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cagiano, R1
De Salvia, MA1
Giustino, A1
Siro Brigiani, G1
Cuomo, V1

Other Studies

1 other study available for haloperidol and Growth Disorders

ArticleYear
Behavioral and neurochemical changes produced in rats by developmental treatments with psychotropic drugs.
    Annali dell'Istituto superiore di sanita, 1993, Volume: 29, Issue:1

    Topics: Animals; Animals, Newborn; Behavior, Animal; Benzodiazepines; Dopamine Antagonists; Embryonic and Fe

1993